Kirkland & Ellis LLP represented Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, in its sale announced today to Prestige Brands Holdings, Inc.(NYSE:PBH) for $750 million in cash. Prestige Brands anticipates closing on this transaction during the first half of this fiscal year, subject to customary closing conditions, including clearance under the Hart-Scott Rodino Antitrust Improvements Act of 1976. Financing for the transaction is expected from a combination of cash on the balance sheet, use of Prestige’s revolving credit agreement, and an add-on to its existing term loan.
The Kirkland team includes corporate partners David Breach and Noah Boyens and associate Brian Raynor, and debt finance partners Christopher Kirkham and Kristopher Ring. All are based in San Francisco, except for Ring, who is based in Los Angeles.
